Diabetes-mediated Interleukin (IL)-17A enhances retinal pathogenesis in Type II diabetics with retinopathy

被引：0
|
作者：
Taylor, Patricia R. [1 ,2 ]
机构：
[1] Case Western Reserve Univ, Ophthalmol, Cleveland, OH USA
[2] Louis Stokes VA Med Ctr, Res, Med Res Serv, Cleveland, OH USA
来源：
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2023年 / 64卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
引用
收藏
页数：2
相关论文
共 39 条
  • [31] Peripheral Blood Mononuclear Cells from Patients with Type 1 Diabetes and Diabetic Retinopathy Produce Higher Levels of IL-17A, IL-10 and IL-6 and Lower Levels of IFN-γ-A Pilot Study
    Obasanmi, Gideon
    Lois, Noemi
    Armstrong, David
    Hombrebueno, Jose M. Romero
    Lynch, Aisling
    Chen, Mei
    Xu, Heping
    CELLS, 2023, 12 (03)
  • [32] The angiotensin II type 2 receptor activates flow-mediated outward remodelling through T cells-dependent interleukin-17 production
    Caillon, Antoine
    Grenier, Celine
    Grimaud, Linda
    Vessieres, Emilie
    Guihot, Anne-Laure
    Blanchard, Simon
    Lelievre, Eric
    Chabbert, Marie
    Foucher, Etienne D.
    Jeannin, Pascale
    Beauvillain, Cline
    Abraham, Pierre
    Loufrani, Laurent
    Delneste, Yves
    Henrion, Daniel
    CARDIOVASCULAR RESEARCH, 2016, 112 (01) : 515 - 525
  • [33] Retinal sensitivity in subjects with type 2 diabetes mellitus: Sankara Nethralaya Diabetic Retinopathy Epidemiology and Molecular Genetics Study (SN-DREAMS II, Report No. 4)
    Gella, Laxmi
    Raman, Rajiv
    Kulothungan, Vaitheeswaran
    Pal, Swakshyar Saumya
    Ganesan, Suganeswari
    Sharma, Tarun
    BRITISH JOURNAL OF OPHTHALMOLOGY, 2016, 100 (06) : 808 - 813
  • [34] Interleukin 17 Production Induced by Angiotensin Ii Type 2 Receptor Activation in T Cells Drives Flow-mediated Outward Remodeling of Mouse Resistance Arteries
    Caillon, Antoine
    Grenier, Celine
    Grimaud, Linda
    Phuc Minh Chau Ngu Yen
    Toutain, Bertrand
    Loufrani, Laurent
    Delneste, Yves
    Henrion, Daniel
    HYPERTENSION, 2013, 62 (03)
  • [35] SGLT2 inhibitor empagliflozin negatively regulates IL-17A/IL-23 axis-mediated inflammatory responses in type 2 diabetes with NAFLD via mTOR autophagy pathway
    Meng, Z.
    Sun, B.
    Chen, L.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2019, 49 : 637 - 637
  • [36] Acceleration of the interleukin-1 receptor antagonist (IL-1Ra) trajectory precedes the diagnosis of type 2 diabetes by 6 years: the Whitehall II prospective cohort study
    Carstensen, M.
    Herder, C.
    Kivimaki, M.
    Jokela, M.
    Roden, M.
    Shipley, M.
    Witte, D. R.
    Brunner, E. J.
    Tabak, A. R.
    DIABETOLOGIA, 2009, 52 : S21 - S22
  • [37] Association of Neuropeptide-Y (NPY) and Interleukin-1beta (IL1B), Genotype-Phenotype Correlation and Plasma Lipids with Type-II Diabetes
    Patel, Roma
    Dwivedi, Mitesh
    Mansuri, Mohmmad Shoab
    Ansarullah
    Laddha, Naresh C.
    Thakker, Ami
    Ramachandran, A. V.
    Begum, Rasheedunnisa
    PLOS ONE, 2016, 11 (10):
  • [38] Protective effects of Nebivolol against interleukin-1β (IL-1β)-induced type II collagen destruction mediated by matrix metalloproteinase-13 (MMP-13)
    Zhigang Li
    Baoyi Liu
    Dewei Zhao
    BenJie Wang
    Yupeng Liu
    Yao Zhang
    Fengde Tian
    Borui Li
    Cell Stress and Chaperones, 2017, 22 : 767 - 774
  • [39] Protective effects of Nebivolol against interleukin-1β (IL-1β)-induced type II collagen destruction mediated by matrix metalloproteinase-13 (MMP-13)
    Li, Zhigang
    Liu, Baoyi
    Zhao, Dewei
    Wang, BenJie
    Liu, Yupeng
    Zhang, Yao
    Tian, Fengde
    Li, Borui
    CELL STRESS & CHAPERONES, 2017, 22 (06): : 767 - 774
1234